| Symbol | IBOGF |
|---|---|
| Name | UNIVERSAL IBOGAINE INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6C 2T5 Canada BC Suite 704, 595 Howe Street |
| Telephone | +1 403-850-7847 |
| Fax | — |
| — | |
| Website | https://universalibogaine.com |
| Incorporation | CA |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 7/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Deloitte LLP - Calgary, Alberta (Canada); |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | 0001774925 |
| Description | Universal Ibogaine Inc. is a Canadian life sciences company with a mission to create a new standard in addiction treatment using ibogaine, a plant derived substance which has been proven to aid in detoxification from a variety of addictions. Additional info from OTC: |
No news found.